Insurance Status and the Risk of Severe Respiratory Syncytial Virus Disease in United States Preterm Infants Born at 32–35 Weeks Gestational Age | Zendy

Jeremy Franklin | Zendy; Evan J. Anderson | Zendy; Xionghua Wu | Zendy; Christopher S. Ambrose | Zendy; Eric A. F. Simões | Zendy

Open Access

Insurance Status and the Risk of Severe Respiratory Syncytial Virus Disease in United States Preterm Infants Born at 32–35 Weeks Gestational Age

Author(s) -

Jeremy Franklin,

Evan J. Anderson,

Xionghua Wu,

Christopher S. Ambrose,

Eric A. F. Simões

Publication year - 2016

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofw163

Subject(s) - medicine , palivizumab , hazard ratio , pediatrics , emergency department , gestational age , incidence (geometry) , confidence interval , risk factor , public health , pregnancy , respiratory system , physics , psychiatry , biology , optics , genetics , nursing

This analysis evaluated the association of public versus private insurance with other risk factors and RSV disease in the REPORT study of preterm infants born at 32 to 35 weeks' gestational age who did not receive RSV immunoprophylaxis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research